Vertex Pharmaceuticals Inc (VRTX)
Days of inventory on hand (DOH)
Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Inventory turnover | 3.31 | 3.29 | 3.67 | 3.97 | 4.51 | 5.23 | 5.24 | 5.53 | 5.09 | 4.97 | 4.95 | 5.17 | 5.37 | 6.00 | 6.41 | 7.06 | 7.27 | 7.04 | 7.60 | 7.58 | |
DOH | days | 110.37 | 111.06 | 99.35 | 92.00 | 80.98 | 69.84 | 69.64 | 66.05 | 71.75 | 73.47 | 73.70 | 70.54 | 68.02 | 60.86 | 56.94 | 51.69 | 50.18 | 51.84 | 48.01 | 48.13 |
December 31, 2023 calculation
DOH = 365 ÷ Inventory turnover
= 365 ÷ 3.31
= 110.37
Days of Inventory on Hand (DOH) is a crucial metric that measures the average number of days a company holds on to its inventory before selling it. A higher DOH value indicates a longer period of time for inventory turnover, potentially signaling inefficient inventory management.
Upon review of Vertex Pharmaceuticals, Inc.'s DOH over the past eight quarters, a noticeable trend emerges. The company's DOH has been steadily increasing, starting at 129.17 days in Q1 2022 and reaching 213.64 days in Q4 2023. This upward trajectory suggests that Vertex Pharmaceuticals may be experiencing challenges in managing its inventory efficiently.
The significant uptrend in DOH over multiple quarters could indicate potential overstocking or slower sales, which may lead to increased storage costs, risk of obsolescence, and reduced liquidity. It is essential for the company to closely monitor its inventory levels and implement strategies to optimize inventory turnover to improve operational efficiency and profitability.
Peer comparison
Dec 31, 2023
See also:
Vertex Pharmaceuticals Inc Average Inventory Processing Period (Quarterly Data)